Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Vascutek Gelsoft Plus ERS Vascular Graft

K-Number: K202703 · 2021-04-06

Decision Date2021-04-06
Product CodeDSY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Vascutek Gelsoft Plus ERS Vascular Graft is a medical device manufactured by Vascutek, Ltd.. It received FDA 510(k) clearance on 2021-04-06 under approval number K202703. The device is classified under product code DSY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Vascutek Gelsoft Plus ERS Vascular Graft?

Vascutek Gelsoft Plus ERS Vascular Graft is a medical device that received FDA 510(k) clearance on 2021-04-06. It is manufactured by Vascutek, Ltd.. The 510(k) number is K202703.

When was Vascutek Gelsoft Plus ERS Vascular Graft approved by the FDA?

Vascutek Gelsoft Plus ERS Vascular Graft received FDA 510(k) clearance on 2021-04-06, under approval number K202703.

What company makes Vascutek Gelsoft Plus ERS Vascular Graft?

Vascutek Gelsoft Plus ERS Vascular Graft is manufactured by Vascutek, Ltd..

What is the FDA product code for Vascutek Gelsoft Plus ERS Vascular Graft?

The FDA product code for Vascutek Gelsoft Plus ERS Vascular Graft is DSY.

Related Clinical Trials

Other Devices by Vascutek, Ltd.

View all 7 devices →

Related Devices (Code: DSY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.